Appointment | April 05, 2026
Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
Board approves five-year appointment, subject to shareholder nod through postal ballot
Board approves five-year appointment, subject to shareholder nod through postal ballot
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
Its a major breakthrough for women’s ovarian cancer care in Europe
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
Subscribe To Our Newsletter & Stay Updated
